AC Immune SA Institutionelles Eigentum
Was ist das Institutionelles Eigentum von AC Immune SA?
Institutionelles Eigentum von AC Immune SA ist 18.04%
Was ist die Definition von Institutionelles Eigentum?
Institutionelles Eigentum ist der Betrag der verfügbaren Aktien eines Unternehmens, das sich im Besitz von Investmentfonds oder Pensionskassen, Versicherungsgesellschaften, Wertpapierfirmen, Stiftungen oder anderen großen Körperschaften befindet, die Fonds für Dritte verwalten.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Institutionelles Eigentum von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu AC Immune SA
Was macht AC Immune SA?
ac immune is a clinical-stage swiss-based biopharmaceutical company, listed on nasdaq, which aims to become a global leader in precision medicine for neurodegenerative diseases. the company designs, discovers and develops therapeutic as well as diagnostic products intended to prevent and modify diseases caused by misfolding proteins. ac immune’s two proprietary technology platforms create antibodies, small molecules and vaccines designed to address a broad spectrum of neurodegenerative indications, such as alzheimer’s disease (ad). the company’s pipeline features nine therapeutic and three diagnostic product candidates – with five product candidates currently in clinical trials. the most advanced of these is crenezumab, a humanized anti-amyloid-β monoclonal igg4 antibody that targets monomeric and aggregated forms of amyloid-β, with highest affinity for neurotoxic oligomers. crenezumab is currently in two phase 3 clinical studies for ad, under a global program conducted by the collabor
Unternehmen mit institutionelles eigentum ähnlich AC Immune SA
- Mabpharm hat Institutionelles Eigentum von 18.00%
- Greentown Service Co hat Institutionelles Eigentum von 18.00%
- Big River Gold hat Institutionelles Eigentum von 18.01%
- Zhejiang New Century Hotel Management Co hat Institutionelles Eigentum von 18.02%
- ProShares Trust - ProShares Short S&P500 hat Institutionelles Eigentum von 18.04%
- Adriatic Metals PLC hat Institutionelles Eigentum von 18.04%
- AC Immune SA hat Institutionelles Eigentum von 18.04%
- TwentyFour Select Monthly Income Fund hat Institutionelles Eigentum von 18.04%
- IIFL Securities hat Institutionelles Eigentum von 18.05%
- adesso AG hat Institutionelles Eigentum von 18.05%
- adesso SE hat Institutionelles Eigentum von 18.05%
- Western Asset Municipal High Income Fund Inc hat Institutionelles Eigentum von 18.06%
- Metalla Royalty and Streaming Ltd hat Institutionelles Eigentum von 18.06%